By Dr. Martine Dehlinger-Kremer, Vice President, Global Medical and Regulatory Affairs
Challenges of the Previous Clinical Trials Directive
The time and costs of conducting clinical trials in the European Union grew significantly.
Worse yet, there was little cooperation among the Member States and no pooling of expert knowledge. As a result, the number of clinical trial applications in the EU fell by 25 percent from 2007 to 2011.